Serendipity Partners is a strategic and hands-on investor and partner that brings deep sector expertise to Nordic healthcare companies. They are dedicated to investing in companies that benefit both patients and society. With a focus on healthcare companies in Europe, particularly in the Nordics, Serendipity Partners seeks to establish long-term partnerships and influential ownership positions.

What sets Serendipity Partners apart is their team, which consists of individuals with extensive medical and scientific knowledge, as well as financial and operational expertise. They have raised NOK 2. 0 billion across two funds and are registered by The Financial Supervisory Authority of Norway.

In terms of their investment approach, Serendipity Partners looks for partnerships with public and family business owners, as well as excellent management teams. They have a conservative risk approach, avoiding excessive leverage and prioritizing mature cash flow positive companies. Serendipity Partners' knowable value proposition allows them to make informed investment decisions through rigorous analysis.

They are committed to active ownership, working closely with management to enhance the value of companies organically or through acquisitions. Additionally, they align management's interests with those of their investors through personal investment and meaningful equity incentives. While the brand does not currently possess ownership in listed shares, they have a diverse portfolio of healthcare companies.

Some of their notable investments include Medu, a Nordic medtech distribution and service platform, and TOPRO Mobility, one of Europe's leading producers of products for assisted living. Overall, Serendipity Partners is a trusted and knowledgeable partner in the healthcare industry, investing in companies that make a positive impact on patients and society